BioMedNewsBreaks – Revive Therapeutics Ltd. (CSE: RV) (OTC: RVVTF) Receives IRB Approval for Bucilliamine COVID-19 Treatment Program

Revive Therapeutics (CSE: RVV) (OTC: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced that is has received approval from the independent Institutional Review Board (“IRB”) for one of its programs. The program is Revive’s expanded access protocol (“EAP”) for compassionate use of Bucillamine in the treatment of COVID-19. The EAP comprises a multi-center, open-label study of Bucillamine in hospitalized patients suffering from severe COVID-19. The study calls for patients to receive Bucillamine 200 mg orally, three times a day for up to 14 days. Patients will be monitored to evaluate the safety and efficacy of Bucillamine at that dosage. Follow-up safety assessments will also be performed. “With the IRB approval of the expanded access protocol by Advarra, a premier IRB services company in North America, hospitalized patients with severe COVID-19 may access Bucillamine under the FDA compassionate use program under medical supervision by their physician,” Revive CEO Michael Frank stated in the press release. “The EAP serves as an option for patients that are not eligible for inclusion criteria in our Phase 3 clinical study in COVID-19, and the resulting data from the EAP will be valuable in supporting our clinical development of Bucillamine.”

To view the full press release, visit http://ibn.fm/dkFIX

About Revive Therapeutics Ltd.

Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug-development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations. Currently, Revive is exploring the use of Bucillamine for the potential treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. With its recent acquisition of Psilocin Pharma Corp., Revive is advancing the development of psilocybin-based therapeutics in various diseases and disorders. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases, and the company was granted FDA orphan drug status designation for the use of cannabidiol (“CBD”) to treat autoimmune hepatitis (liver disease) and reperfusion injury from organ transplantation. For more information about the company, visit www.ReviveThera.com.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Latest News

Soleimani, a general who became Iran icon by targeting US

Sep 22, 2020

TEHRAN, Iran — For Iranians whose icons since the Islamic Revolution have been stern-faced clergy, Maj. Gen. Qassem Soleimani widely represented a figure of national resilience in the face of four decades of U.S. pressure. For the U.S. and Israel, he was a shadowy figure in command of Iran's proxy forces, responsible for fighters in Syria backing President Bashar Assad and for the deaths of American troops in Iraq. Solemani survived the horror of Iran’s long war in the 1980s with Iraq to take control of the Revolutionary Guard’s elite Quds Force, responsible for the Islamic Republic’s foreign campaigns. Relatively...

Muslim hajj pilgrims ascend Mount Arafat for day of worship

Sep 22, 2020

MOUNT ARAFAT, Saudi Arabia — More than 2 million Muslims are gathered at the sacred hill of Mount Arafat in Saudi Arabia for an intense day of worship and reflection on what's considered the climax of the Islamic hajj pilgrimage. Some had tears streaming down their faces as the men, wearing simple white garments, and women raised their hands in worship on the slopes of the rocky hill. Many walked through the pre-dawn darkness early Saturday to the hill where the Prophet Muhammad delivered his final sermon some 1,400 years ago, calling for equality and unity among Muslims. One of...

Saudi changes allow women to travel without male consent

Sep 22, 2020

DUBAI, United Arab Emirates — Saudi Arabia published new laws early Friday that loosen restrictions on women by allowing any citizen to apply for a passport and travel freely, ending a long-standing guardianship policy that gave men control over women. The changes are a potential game-changer for Saudi women's rights in the kingdom. The legal system has long been criticized because it treated women as minors throughout their adult lives, requiring they have a man's consent to obtain a passport or travel abroad. Often a woman's male guardian is her father or husband, and in some cases a woman's own...

The Latest: UN chief calls for 'maximum restraint' in Gulf

Sep 22, 2020

DUBAI, United Arab Emirates — The Latest on the tensions between the United States and Iran (all times local): 10:45 p.m. U.N. Secretary-General Antonio Guterres is again calling for "maximum restraint" in the Persian Gulf region and warning all parties that a new confrontation "would be a catastrophe." U.N. deputy spokesman Farhan Haq reiterated the U.N. chief's plea to avoid any escalation when asked Thursday for Guterres' reaction to Britain saying Iranian vessels tried to block one of its oil tankers in the Gulf. Haq said the U.N. hopes all nations "will take steps to avoid" an escalation and confrontation....

Egypt demands Christie's halt auction of King Tut statue

Sep 22, 2020

CAIRO — Egypt has tried to halt the auction of a 3,000-year-old stone sculpture of the famed boy pharaoh Tutankhamun at Christie's in London, while the auction house said its sale was legal. The statue — a brown quartzite head depicting King Tut — is scheduled to be auctioned off in July, and could generate more than $5 million, according to Christie's. The artifact features King Tut's full mouth with slightly drooping lower lips and almond-shaped eyes. For many, King Tut is the ultimate symbol of ancient Egypt's glory. Howard Carter discovered the pharaoh's nearly intact tomb in 1922 in...

About Us

Originally founded in 2015, Voyage Times publishes articles on travel and lifestyle for travelers, leisure seekers, and culture hunters from around the world.

Contact us: sales[at]voyagetimes.com

Subscribe Now!

Quick Links

HomePress